Cinctive Capital Management LP Oncocyte Corp Transaction History

Cinctive Capital Management LP

  • $1.72 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.86 - $1.53 $104,369 - $185,680
-121,360 Reduced 86.12%
19,565 $18,000
Q4 2021

Feb 14, 2022
SELL
$2.04 - $3.59 $119,625 - $210,517
-58,640 Reduced 29.38%
140,925 $306,000
Q3 2021

Nov 15, 2021
BUY
$3.53 - $5.89 $139,664 - $233,037
39,565 Added 24.73%
199,565 $710,000
Q2 2021

Aug 16, 2021
BUY
$3.77 - $6.0 $603,200 - $960,000
160,000 New
160,000 $918,000

Others Institutions Holding OCX

# of Institutions
3
Shares Held
411K
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $294M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email